Scopus Asset Management’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-750,000
Closed -$18.4M 278
2026
Q1
$18.4M Buy
+750,000
New +$17.8M 0.32% 111
2024
Q4
Sell
-500,000
Closed -$8.13M 229
2024
Q3
$8.13M Sell
500,000
-150,000
-23% -$2.54M 0.14% 182
2024
Q2
$12.3M Buy
+650,000
New +$13.5M 0.25% 126
2023
Q4
Sell
-300,000
Closed -$5.46M 247
2023
Q3
$5.46M Buy
+300,000
New +$5.29M 0.16% 152
2021
Q4
Sell
-184,800
Closed -$3.47M 311
2021
Q3
$3.47M Buy
+184,800
New +$3.56M 0.06% 261
2020
Q3
Sell
-250,000
Closed -$1.92M 256
2020
Q2
$1.92M Buy
+250,000
New +$1.82M 0.05% 182

Other funds holding CSTM

Scopus Asset Management's CSTM Position: Q2 2026 in Review

Scopus Asset Management increased its Constellium (CSTM) stake by 3% in Q2 2026, buying an estimated $1.61M and bringing the position to 1,731,708 shares worth $55.2M. The position accounts for 0.78% of the portfolio, ranked #31.

Scopus Asset Management first reported a position in CSTM in Q2 2013 and has held it in 30 quarters since. 389 funds tracked by Wall St. Rank hold CSTM as of Q2 2026.

  • Scopus Asset Management held 1,731,708 shares of Constellium worth $55.2M as of Q2 2026.
  • Scopus Asset Management bought 50,000 Constellium shares in Q2 2026, an estimated $1.61M.
  • Constellium made up 0.78% of Scopus Asset Management's portfolio in Q2 2026, its #31 holding.
  • Scopus Asset Management first reported a position in Constellium in Q2 2013 and has held it in 30 quarters since.
  • 389 funds tracked by Wall St. Rank held Constellium as of Q2 2026.

Based on Scopus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.